1. Carbon dots nanoparticles as an effective gate for PDT
- Author
-
Algarra, M., Nešić, M. D., Soto, J., Urrutia, A., Imas, J. J., Dučić, T., Petković, M., Algarra, M., Nešić, M. D., Soto, J., Urrutia, A., Imas, J. J., Dučić, T., and Petković, M.
- Abstract
The promising strategy for targeted cancer treatment is to employ light as an external activator of a drug accumulated in tumor tissue. This approach is so-called photodynamic therapy (PDT) and can be used for diagnostic purposes. A photosensitizer, molecular oxygen, and laser light are the three significant components of Type II PDT, and the mechanism is the catalysis of the production of reactive oxygen species that lead to the oxidative damage of cellular molecules inducing cancer cell death [1]. Fluorescent carbon dots (CDs), spherical nanoparticles with size < 10 nm that can function as bioimaging agents and photosensitizers, have demonstrated significant potential in cancer theranostics [2]. Here, we have created Nitrogen co-doped carbon dots (N-CDs) surface decorated with organometallics compound, based on the Ru complex (Ru@N-CDs) [3,4] that were active in inducing biomolecular changes in ovarian cancer cell line upon illumination. Upon illumination, the most significant structural changes occurred in ovarian cancer cells and were detected in the protein region; we postulate interference with signaling pathways involved in regulating cancer cell growth and tumor progression. However, the limitation of light is the depth of penetration through the tissues, which prevents significant therapeutic effects on deep tumors. A strategy to overcome this is to use optical fibers that have coatings fabricated from the N-CDs, thus developing a so-called lab-on fiber system. The light propagating through the fiber [4] can activate the overall coating on the optical fiber surface with the presence of Ru@N-CDs. We hypothesize that the activation by the light results in the locally increased ROS production combined with enhanced release of the Ru complex from the surface, similar to the Ru@TiO2 NCS [5]. Our preliminary results demonstrate a high potential of the lab-on-fiber system in therapy against ovarian cancer that can resist traditional chemotherapeutic approaches.
- Published
- 2023